NI, N., R, B., AA, A., AF, A., MS, A., & MA, A. (2026). Enhancement of oral bioavailability of risedronate through xyloglucan rafts. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 28, 15525. https://doi.org/10.3389/jpps.2025.15525
Chicago Style (17th ed.) CitationNI, Namazi, Bafail R, Alanezi AA, Almuqati AF, Alshammari MS, and Alghamdi MA. "Enhancement of Oral Bioavailability of Risedronate Through Xyloglucan Rafts." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques 28 (2026): 15525. https://doi.org/10.3389/jpps.2025.15525.
MLA (9th ed.) CitationNI, Namazi, et al. "Enhancement of Oral Bioavailability of Risedronate Through Xyloglucan Rafts." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, vol. 28, 2026, p. 15525, https://doi.org/10.3389/jpps.2025.15525.